Rheumatology and psychiatry: allies in times of COVID-19

Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel F. Ugarte-Gil

Research output: Contribution to journalReview articlepeer-review

Abstract

The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.

Original languageEnglish
Pages (from-to)3363-3367
Number of pages5
JournalClinical Rheumatology
Volume40
Issue number8
DOIs
StatePublished - Aug 2021

Bibliographical note

Funding Information:
The authors thank Renato D. Alarc?n, MD, MPH, Professor Emeritus of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN; and Honorio Delgado Chair, Universidad Peruana Cayetano Heredia, Lima, Peru, for providing expert assistance in the review of the manuscript.

Publisher Copyright:
© 2021, International League of Associations for Rheumatology (ILAR).

Keywords

  • COVID-19
  • Coronavirus disease 2019
  • Mental health
  • Psychiatrists
  • Rheumatic diseases
  • Rheumatologists

Fingerprint

Dive into the research topics of 'Rheumatology and psychiatry: allies in times of COVID-19'. Together they form a unique fingerprint.

Cite this